These drugs neither increase ACE2 expression within the motile cilia of upper and lower airway epithelial cells [38] nor increase the risk of COVID-19 and the likelihood of a positive test [39,40], even when adjusted for age, gender, and cardiovascular risk [41]. This evidence concerns the gene ACE2 and COVID-19.